Non-neutralizing Antibodies Targeting the V1V2 Domain of HIV Exhibit Strong Antibody-Dependent Cell-mediated Cytotoxic Activity

The development of an effective vaccine against HIV-1 has proven to be challenging. Broadly neutralizing antibodies (bNAbs), whilst exhibiting neutralization breadth and potency, are elicited only in a small subset of infected individuals and have yet to be induced by vaccination. Case-control studi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Sci Rep
Egile Nagusiak: Mayr, Luzia M., Decoville, Thomas, Schmidt, Sylvie, Laumond, Géraldine, Klingler, Jéromine, Ducloy, Camille, Bahram, Seiamak, Zolla-Pazner, Susan, Moog, Christiane
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group UK 2017
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5627290/
https://ncbi.nlm.nih.gov/pubmed/28978939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-12883-6
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak